Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
SAR448632 · 1 trial · 1 indication
Assessment of AEs/TEAEs including ISRs.
Clinical laboratory evaluations (hematology, biochemistry, coagulation, urinalysis); Vital signs; 12-lead ECG (heart rate, PR, QRS, QT, QTcF).
| Arm | Type | Description |
|---|---|---|
| SAR448632 | EXPERIMENTAL | Participants will receive a single dose of SAR448632 by SC injection or infusion on Day 1 only. |
| Placebo | PLACEBO_COMPARATOR | The placebo administration will match the dosing planned for SAR448632 |
| Name | Type | Description |
|---|---|---|
| Placebo | DRUG | Administration method will match SAR448632 |
| SAR448632 | DRUG | Route of administration: SC injection or infusion |
Inclusion Criteria: * Certified as healthy by a comprehensive clinical assessment (detailed medical history and complete physical examination). * Body weight between 45.0 and 95.0 kg, inclusive; Body Mass Index (BMI) between 18.5 and 27.9 kg/m², inclusive. * Contraceptive use by male or female part...